A study of two methods for estimating plasma fibrinogen and the effect of epsilon aminocaproic acid and protamine
Open Access
- 1 July 1971
- journal article
- research article
- Published by BMJ in Journal of Clinical Pathology
- Vol. 24 (5) , 467-471
- https://doi.org/10.1136/jcp.24.5.467
Abstract
Fibrinogen concentrations were determined in normal plasma and in plasma from patients with high and low levels. There was a good correlation between the results of a rapid semi-quantitative fibrinogen titre technique and those of a quantitative assay of coagulable fibrinogen. In normal subjects fibrinogen levels were not significantly influenced by taking blood into epsilon aminocaproic acid (EACA) or by the addition of protamine to plasma. In patients with the defibrination syndrome in whom increased plasma fibrinolysis was not detected, fibrinogen levels were not affected by taking blood into EACA but considerably increased levels were observed after the addition of protamine to plasma. In patients undergoing thrombolytic therapy the fibrinogen levels measured were increased both in blood taken into EACA and in plasma containing protamine. It is suggested that EACA acted by preventing lysisin vitrowhilst protamine counteracted abnormal fibrin polymerization. The pattern of results may be of diagnostic importance.Keywords
This publication has 11 references indexed in Scilit:
- Obstetric Defibrination Syndrome with Abnormal Thrombin-Fibrinogen Reaction and Immunologically Reactive Altered Fibrinogen in SerumScandinavian Journal of Haematology, 2009
- Defibrination syndrome with defective thrombin-fibrinogen reaction reversible by protamineJournal of Clinical Pathology, 1965
- The Estimation of Fibrinogen A RevisionScandinavian Journal of Clinical and Laboratory Investigation, 1965
- Haematology and the extracorporeal circulationJournal of Clinical Pathology, 1963
- SIGNIFICANCE OF CRYOPROFIBRIN IN FIBRINOGEN-FIBRIN CONVERSIONThe Journal of Experimental Medicine, 1962
- PATHOGENESIS OF THE COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (“FIBRINOLYTIC”) STATES. I. THE SIGNIFICANCE OF FIBRINOGEN PROTEOLYSIS AND CIRCULATING FIBRINOGEN BREAKDOWN PRODUCTS*Journal of Clinical Investigation, 1962
- Determination of Fibrinogen and Fibrinogenolytic ActivityThrombosis and Haemostasis, 1962
- DEFIBRINATION SYNDROME IN PREGNANCY VALUE OF VARIOUS DIAGNOSTIC TESTSThe Lancet, 1958
- The determination of plasma fibrinogen by turbidity with ammonium sulfateArchives of Biochemistry and Biophysics, 1953
- A NEW METHOD FOR THE DETERMINATION OF FIBRINOGEN IN SMALL SAMPLES OF PLASMA1951